Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa
Open Access
- 1 January 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (1), 22-30
- https://doi.org/10.1093/jac/dkh505
Abstract
Objectives: Quinolone resistance in the opportunistic pathogen Pseudomonas aeruginosa is commonly caused by mutations that alter the target molecules DNA gyrase/topoisomerase IV, or cause activation of various efflux systems. We have analysed the effect of quinolone resistance caused by DNA gyrase/topoisomerase IV mutations on bacterial fitness. Methods: Norfloxacin-resistant mutants were isolated and by DNA sequencing the mutations conferring resistance were identified. Mutant fitness was determined by measuring growth rates in vitro. Mutants with reduced growth rates were serially passaged to obtain growth-compensated mutants. The level of DNA supercoiling was determined by isolating plasmid DNA from the susceptible, resistant and compensated mutants and comparing the topoisomer distribution patterns by gel electrophoresis in the presence of chloroquine. Results: Low-level resistance (4–48 mg/L) was caused by single mutations in gyrA or gyrB. Among these strains, three out of eight mutants showed lower fitness, whereas high-level resistant (>256 mg/L) mutants with double mutations in gyrA and parC, parE, nfxB or unknown genes all showed a reduced fitness. Slow-growing resistant mutants with a gyrA mutation had decreased DNA supercoiling. After serial passage in laboratory medium, mutant fitness was increased by compensatory mutation(s) that restored supercoiling to normal levels. The compensatory mutation(s) was not located in any of the genes (gyrAB, topA, parCE, hupB, fis, hupN, himAD or PA5348) that were expected to affect supercoiling. Conclusions: Our results show that ‘no cost’ and compensatory mutations are common in quinolone-resistant P. aeruginosa.Keywords
This publication has 32 references indexed in Scilit:
- Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agentsThorax, 2003
- Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, ChinaAntimicrobial Agents and Chemotherapy, 2003
- Fitness of in vitro selected Pseudomonas aeruginosanalB and nfxB multidrug resistant mutantsJournal of Antimicrobial Chemotherapy, 2002
- Mechanism of plasmid-mediated quinolone resistanceProceedings of the National Academy of Sciences, 2002
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatmentDrug Resistance Updates, 2000
- Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998Drugs, 1999
- Quinolone resistance from a transferable plasmidThe Lancet, 1998
- A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complexAntimicrobial Agents and Chemotherapy, 1993
- The distribution of the numbers of mutants in bacterial populationsJournal of Genetics, 1949